PT  - JOURNAL ARTICLE
AU  - Antillon, Marina
AU  - Huang, Ching-I
AU  - Rock, Kat S
AU  - Tediosi, Fabrizio
TI  - Economic evaluation of disease elimination: an extension to the net-benefit framework and application to human African trypanosomiasis
AID  - 10.1101/2021.02.10.20181974
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.10.20181974
4099  - http://medrxiv.org/content/early/2021/05/02/2021.02.10.20181974.short
4100  - http://medrxiv.org/content/early/2021/05/02/2021.02.10.20181974.full
AB  - The global health community has earmarked a number of diseases for elimination or eradication, and these goals have often been praised on the premise of long-run cost-savings. However, decision-makers must contend with a multitude of demands on health budgets in the short- or medium-term, and costs-per-case often rise as the burden of a disease falls, rendering such efforts beyond the cost-effective use of scarce resources. In addition, these decisions must be made in the presence of substantial uncertainty regarding the feasibility and costs of elimination or eradication efforts. Therefore, analytical frameworks are necessary to consider the additional effort for reaching global goals, like elimination or eradication, that are beyond the cost-effective use of country resources. We propose a modification to the net-benefit framework to consider the implications of switching from an optimal strategy, in terms of cost-per-burden-averted, to a strategy with a higher likelihood of meeting the global target of elimination of transmission by a specified date. We illustrate the properties of our framework by considering the economic case of efforts to eliminate transmission of gambiense human African trypanosomiasis (gHAT), a vector-borne parasitic disease in West and Central Africa, by 2030.Significance Statement Various diseases are earmarked for elimination by the global health community. While the health economic implications of elimination have been discussed before, the combination of uncertainty, cost-effectiveness in terms of cases averted, and elimination in the face of rising per-case costs has not been tackled before. We propose an approach that considers the tension between the dual objectives of cost-effectiveness and elimination while incorporating uncertainty in these objectives. We apply our method to strategies against human African trypanosomiasis in three settings, but this method could be directly applied to simulation-based studies of the cost-effectiveness of other disease elimination efforts. The method yields common metrics of efficiency when stakeholders have different objectives.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is not a clinical trial.Funding StatementThis work was funded by the Bill and Melinda Gates Foundation (BMGF): Human African Trypanosomiasis Modelling and Economic Predictions for Policy (HAT MEPP) project (OPP1177824) and the NTD Modelling Consortium (OPP1184344, OPP1156227, and OPP1186851).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Because no personal data were used (only projections and data from the literature) the submitted work is exempt from ethics oversight.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code to reproduce the analysis contained in this paper are available through OpenScienceFramework (OSF). https://osf.io/fh6ca/